Italian scientists at the Laboratory of Reproductive Technology in Cremona announce Prometea, the first horse (Equus caballus) clone created from a skin cell, raising hopes that clones could one day perpetuate the genetic line of castrated geldings.
French and Chinese scientists unveil Ralph the cloned laboratory rat (Rattus norvegicus). Rats had been tough to clone because rat eggs divide before the point at which the donor DNA is injected, so the technique relied on using drugs to inhibit division. After Dolly, scientists thought they would soon be able to clone many other mammals. Some envisaged an industry of cloning applications, from the production of medicines in live bioreactors -cloned, genetically modified livestock -to the creation of herds of cloned food animals.
Scientists have made some progress towards potential applications. For instance, they have cloned transgenic pigs that might one day be used as organ donors, transgenic cows and goats that produce proteins that some humans lack -they have even cloned pets. But the low efficiency of the cloning process has stymied industrial development, and most companies set up to commercialize cloning have shut down.
Only 2-5% of cloned animal embryos grow into healthy offspring. This is slightly better than a decade ago -Dolly was the only lamb born from 277 cloned embryos -but it is still far below the efficiency demanded by industry.
There are several reasons why it has been difficult to figure out how cloning works. Early development is slightly different in every species, so cloning a new species is an arduous, trialand-error process that requires scientists to use thousands of eggs. But eggs aren't always easy to obtain, especially for monkeys and humans, and "I think in ten years, people will learn how to convert one cell type to another, without nuclear transfer, without eggs, in a Petri dish," says Jaenisch. "Once we learn all the rules, maybe one day it will be possible." 
